Results 221 to 230 of about 94,325 (274)

Transcriptome analysis of orbital tissue in thyroid eye disease uncovers key pathogenic mediators. [PDF]

Sci Rep
Hua W, Ji X, Chen J, Jiang Z, Chen H, Cui Y, Li M, Lu X, Wang X, Zhang J.   +9 more
europepmc   +1 more source

High-Throughput Tear Proteomics Reveals Multi-Faceted Signatures of Thyroid Eye Disease. [PDF]

Invest Ophthalmol Vis Sci
Li R, Zhang H, Yang L, Pan Y, Wei Y, Sun J, Zhou H.   +6 more
europepmc   +1 more source

Report of Physical Examinations: Religious Communities - Archdiocese of St. Louis [PDF]

, 1965
Gorla, Wayne O.
core   +1 more source

Extending the Graves' Triad: Thyroid Eye Disease, Dermopathy, and Acropachy: A Clinical Response to Teprotumumab. [PDF]

JCEM Case Rep
Lira J, Dixon P, Zaidi M, Kim SM.
europepmc   +1 more source

An Atypical Presentation of Thyroid Eye Disease in a Patient With a Remote History of Graves' Disease. [PDF]

Cureus
Van Buren NL, Yu CY, Bradley EA.
europepmc   +1 more source

Exploring thyroid eye disease in Brazil: insights from a single-center study. [PDF]

Arch Endocrinol Metab
Villagelin D, Perini N, Santos RB, Romaldini JH.   +3 more
europepmc   +1 more source

Rituximab for refractory ocular symptoms in myasthenia gravis with thyroid eye disease: a case report with quantitative MRI assessment. [PDF]

Front Immunol
He D, Li X, Wang B, Wang Y, Yan C, Liu M, Hibert T, Luo S, Zhao C, Xi J.   +9 more
europepmc   +1 more source

Baseline selenium is associated with response to intravenous Methylprednisolone with selenium supplementation for thyroid eye disease in a selenium-sufficient area. [PDF]

Sci Rep
Sung SM, Lee DC.
europepmc   +1 more source

Glymphatic System Dysfunction in Thyroid Eye Disease Associated with Disease Activity and Duration. [PDF]

J Inflamm Res
Zhang H, Jiang M, Liu Y, Lee XN, Fang Z, Li J, Li Y, Sun J, Tao X, Song X, Zhou H, Fan X.   +11 more
europepmc   +1 more source